Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02996097 · ClinicalTrials.gov registry record · NA
Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02996097: Completed NA study, sponsored by Johns Hopkins University.
NCT02996097 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02996097, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of fractional carbon dioxide (CO2) laser therapy immediately followed by intralesional steroid therapy against intralesional steroid therapy alone for the treatment of keloids.
Primary Outcome
Data from POSAS Observer Scale will be collected and reported to assess vascularity, pigmentation, thickness, relief, pliability, and surface area of the keloids chosen for the research study. Total score range: 6-60; Higher scores mean a worse outcome. Mean composite score of the final visit was compared to the mean baseline score.
Interventions
- DEVICE The Lutronic electronic carbon dioxide (eCO2) Plus laser system
- DRUG Intralesional Triamcinolone Acetonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-06-15 |
| Phase | NA |
What the finished NCT02996097 record still lists
NCT02996097 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which The Lutronic electronic carbon dioxide (eCO2) Plus laser system is the first listed.
NCT02996097 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02996097 about?
NCT02996097 is a clinical study titled "Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids". The purpose of this study is to compare the effects of fractional carbon dioxide (CO2) laser therapy immediately followed by intralesional steroid therapy against intralesional steroid therapy alone for the treatment of keloids.
What is the current status of trial NCT02996097?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-04. Estimated completion is 2018-06-15.
What interventions are being tested in trial NCT02996097?
The interventions under investigation include: The Lutronic electronic carbon dioxide (eCO2) Plus laser system (DEVICE), Intralesional Triamcinolone Acetonide (DRUG).
Who is sponsoring clinical trial NCT02996097?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02996097's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia